Provided by Tiger Fintech (Singapore) Pte. Ltd.

Taysha Gene Therapies, Inc.

2.31
-0.0700-2.94%
Post-market: 2.350.0400+1.73%16:51 EDT
Volume:1.32M
Turnover:3.07M
Market Cap:605.22M
PE:-6.91
High:2.42
Open:2.42
Low:2.30
Close:2.38
Loading ...
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Sep 26, 2023

Major Issues Report

Form 8-K - Current report
Sep 19, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Correspondence

Form CORRESP - Correspondence
Aug 29, 2023

Major Issues Report

Form 8-K - Current report
Aug 28, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 25, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 25, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 24, 2023

Major Issues Report

Form 8-K - Current report
Aug 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 18, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jun 28, 2023

Major Issues Report

Form 8-K - Current report
Jun 24, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities